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ABSTRACT The ﬂavivirus capsid protein (C) is separated from the downstream pre-
membrane (PrM) protein by a hydrophobic sequence named capsid anchor (Ca).
During polyprotein processing, Ca is sequentially cleaved by the viral NS2B/NS3 pro-
tease on the cytosolic side and by signal peptidase on the luminal side of the endo-
plasmic reticulum (ER). To date, Ca is considered important mostly for directing
translocation of PrM into the ER lumen. In this study, the role of Ca in the assembly
and secretion of Zika virus was investigated using a pseudovirus-based approach.
Our results show that, while Ca-mediated anchoring of C to the ER membrane is not
needed for the production of infective particles, Ca expression in cis with respect to
PrM is strictly required to allow proper assembly of infectious particles. Finally, we
show that the presence of heterologous, but not homologous, Ca induces degrada-
tion of E through the autophagy/lysosomal pathway.
IMPORTANCE The capsid anchor (Ca) is a single-pass transmembrane domain at the
C terminus of the capsid protein (C) known to function as a signal for the transloca-
tion of PrM into the ER lumen. The objective of this study was to further examine
the role of Ca in Zika virus life cycle, whether involved in the formation of nucleo-
capsid through association with C or in the formation of viral envelope. In this
study, we show that Ca has a function beyond the one of translocation signal, con-
trolling protein E stability and therefore its availability for assembly of infectious par-
ticles.
KEYWORDS capsid anchor, ﬂavivirus, morphogenesis, pseudovirus, viral assembly,
Zika virus
Similar to other members of the Flaviviridae family, which also includes signiﬁcanthuman pathogens such as West Nile virus (WNV) and dengue virus (DENV), Zika
virus (ZIKV) is an enveloped, single-stranded, positive-sense RNA virus (1). The surface
structure of a typical ﬂavivirus particle is formed by 180 copies of the envelope
glycoprotein (E) and the membrane protein (M), which are anchored onto the host-
derived lipid bilayer through their transmembrane domains (TMDs). The viral envelope
encloses a nucleocapsid core composed of the single molecule of RNA genome and
several copies of the capsid protein (C) (2–4).
In all ﬂaviviruses, the viral genome encodes a single open reading frame which is
translated into a polyprotein that is co- and posttranslationally cleaved into three
structural (C, premembrane/membrane [PrM/M], and E) and seven nonstructural pro-
teins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). Cleavage into mature viral proteins
is catalyzed by the virus-encoded NS2B-NS3 protease on the cytosolic side and by the
host signal peptidase and furin at the luminal side of the endoplasmic reticulum (ER)
and Golgi network, respectively (5). Processing of the polyprotein is crucial for virus
replication and regulation of gene expression in the majority of positive-sense RNA
viruses (6, 7). Replication and morphogenesis of ﬂaviviruses occur in close association
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with intracellular membranes (8–11). After translation, virus assembly occurs by bud-
ding of the nucleocapsid into the ER, thus acquiring the membrane envelope together
with proteins E and PrM. During trafﬁc through the Golgi network, furin cleaves PrM to
generate mature and infective virions. Following its cleavage, the Pr peptide remains
associated with the viral particle and dissociates when the virus reaches neutral pH
upon exit from the cell (10, 12–14).
During translation, the structural proteins PrM and E and the nonstructural proteins
NS1 and NS4B are translocated into the ER lumen by TMDs present at the C terminus
of the upstream proteins, which act concomitantly as signal peptides for ER transloca-
tion of the downstream protein and as a stop transfer signal for the upstream one. The
capsid protein (C), the ﬁrst one of the polypeptide, carries a single TMD, also termed a
capsid anchor (Ca), which anchors C to the ER membrane before cleavage by NS2B/NS3
protease and is a translocation signal for PrM into the ER lumen. Instead, PrM and E
proteins have double TMDs; the ﬁrst acts as a stop transfer signal, while the second
serves as a translocation signal for the following protein (E in the case of PrM and NS1
in the case of E) (15). Different studies performed to understand the role of PrM and E
TMDs in viral assembly and release showed that mutations in these regions or inter-
change of them among ﬂaviviruses severely impair virus assembly and release of viral
particles (16–20). However, the role of Ca in the viral life cycle has not been extensively
investigated.
The Ca region consists of three main segments and varies from 14 to 22 amino acids
among the different ﬂaviviruses. The amino-terminal region contains basic residues,
which determine the orientation of the polyprotein insertion into the ER and provides
the cleavage site for the viral protease, and is followed by a core formed by a series of
uninterrupted hydrophobic amino acids and a carboxy-terminal cleavage region which
is relatively hydrophobic but consistent with the (3, 1) rule (21). The ﬂavivirus Ca
region has the requirement to be cleaved sequentially during processing of the
polyprotein. The ﬁrst cleavage takes place on the cytosolic side by the viral protease
NS2B/NS3 releasing mature C in the cytosol, which is followed by cleavage by the host
signal peptidase on the ER luminal side (22–25). This ordered processing, controlled by
the Ca sequence, was shown to be required for efﬁcient assembly of Murray Valley
encephalitic virus (MVEV) and yellow fever virus (YFV) (23, 26).
To date, ﬂavivirus Ca has been considered to function mainly as a signal sequence
for PrM translocation. Here, we show that Ca plays an essential role in controlling
stability of downstream structural polyprotein, thus participating in the fate of virus
assembly.
RESULTS
Role of Ca on ZIKV packaging. The role of the capsid anchor (Ca) on the
production of ZIKV was investigated using a WNV replicon-packaging approach, which
is based on the production of infectious pseudoviral particles by providing in trans the
viral structural proteins expressed from appropriate constructs (27). A schematic rep-
resentation of the structural proteins topology and the sequences at the C-Pr junction
are shown in Fig. 1A and B, respectively. For the production of pseudoviruses, a WNV
replicon that harbors an enhanced green ﬂuorescent protein (EGFP) reporter (WNV-rep)
(27) was cotransfected in HEK293T cells with packing constructs encoding C and PrME
derived from WNV (positive control), ZIKV, or DENV2. The production of infective
pseudoviral particles was analyzed by infecting Vero cells and determining the number
of EGFP-positive cells by cytoﬂuorimetry at 24 h postinfection (hpi) (Fig. 1C).
As shown in Fig. 2A and B, pseudoviruses were efﬁciently produced with both WNV
and ZIKV packaging constructs, but not with DENV2, in agreement with previous
studies showing context-dependent activity of the WNV NS2B/NS3 protease (28). A
mutation in DENV2 (T101G) at the Ca cytosolic cleavage site improved proteolytic
activity and partially restored pseudovirus production (Fig. 2A and B) (28). The produc-
tion of pseudoviruses was further conﬁrmed by Western blot analysis of virions
(obtained from culture supernatants by ultracentrifugation) using anti-ﬂavivirus E
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protein monoclonal antibody (mAb) 4G2 and by detection of replicon RNA in super-
natants using reverse transcription-PCR (RT-PCR) (Fig. 2C). These results show that
pseudovirus infectivity corresponds to the relative levels of secreted particles.
We then investigated the role of Ca in ZIKV life cycle. For this purpose, we generated
different ZIKV chimeric packaging constructs in which the C and/or Ca region, and/or
the ﬁrst 5 amino acids of Pr ([5]), were substituted with the homologous regions from
WNV (shown schematically in Fig. 3A). Cytoﬂuorimetric analysis of cells infected with
pseudoviruses obtained with the different packaging constructs showed that ZIKV
chimeras carrying a heterologous Ca, i.e., CW-CaW-(5W)PrMEZ, CW-CaW-PrMEZ, and CZ-
CaW-PrMEZ (Fig. 3A, constructs 2, 3, and 5, respectively), did not infect Vero cells,
indicating that these replacements were lethal (Fig. 3B and C). In contrast, the chimera
with homologous Ca, i.e., CW-CaZ-PrMEZ (construct 4), produced signiﬁcant levels of
infective particles, as well as the chimera with substitution of the ﬁve Pr N-terminal
amino acids (CZ-CaZ-[5W]PrMEZ, construct 6), albeit in smaller amounts (Fig. 3B and C).
In both cases, the number of infected cells were signiﬁcantly lower than when using the
wild-type ZIKV construct (construct 1). Pseudovirus production was further conﬁrmed
by Western blots. Consistent with the infection assay, secreted pseudoviruses were only
detected in ZIKV constructs with the homologous Ca, suggesting a role for this region
in the assembly and/or secretion of virion particles (Fig. 3D). Furthermore, the intra-
cellular E levels were higher with constructs carrying ZIKV Ca (Fig. 3D). In agreement
with the infection data, the chimera with the heterologous ﬁrst 5 amino acids of Pr
(CZ-CaZ-[5W]PrMEZ, construct 6) showed reduced level of intracellular and secreted E
and was found to signiﬁcantly compromise secretion of viral particles (Fig. 3D).
These results indicate a key role for Ca in the morphogenesis of ZIKV infectious
particles, a function that goes beyond its signal peptide activity for PrM translocation
into the ER lumen.
FIG 1 (A) Schematic representation of the genomic organization of ﬂavivirus structural proteins (upper panel) and
the membrane topology and cleavage sites for NS2B/NS3, furin and signal peptidase, indicated by red, blue,
and black arrows, respectively (lower panel). (B) Sequence of capsid anchor region (Ca; in red) for WNV, ZIKV, and
DENV2. The ﬁrst 5 amino acids of the downstream PrM used in some of the constructs are indicated in blue. The
NS2B/NS3 viral protease and signal peptidase cleavage sites are indicated by arrows. (C) Schematic representation
of the protocol used for the production and detection of pseudoviruses.
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Cytosolic and ER luminal Ca processing. The processing of Ca is a coordinated
step of cleavage by viral and host proteases. The chimeric constructs generated by
replacements at the C-Pr junctions have modiﬁed cleavage site sequences, which could
affect Ca processing and thus potentially affect the production of pseudoviruses. To
examine the effect of these replacements on proteolytic cleavage, N-terminally SV5-
tagged packaging constructs carrying the full ZIKV sequence and the Ca substitution
were generated (SV5-CZ-CaZ-PrMEZ and SV5-CZ-CaW-PrMEZ, respectively) (Fig. 4A).
These constructs were transfected into HEK293T cells in the presence or absence of the
viral protease NS2B/NS3 provided by WNV-rep. Western blot analysis showed that in
the absence of viral protease, C protein was not cleaved since only CPrM and CPrME
unprocessed forms were detected at very low levels (Fig. 4B). Conversely, in the
presence of NS2B/NS3, C was equally processed in both constructs, as represented by
the high levels of SV5-tagged C (Fig. 4B). Similar results were obtained for E protein
(detected with mAb 4G2), further conﬁrming the downstream effect of Ca processing
and the sequential requirement of cytosolic cleavage before signal peptidase luminal
proteolysis (Fig. 4B). As shown in Fig. 4C, the ZIKV SV5-tagged packaging construct was
able to produce infective particles although reduced in comparison to the untagged
version while, as expected, the one with the CaW was not.
These results indicate that the lack of pseudovirus production with the heterologous
CaW was not the consequence of impaired processing on the cytosolic side by the viral
protease.
FIG 2 Production of WNV, DENV2, and ZIKV pseudoviruses. (A) Cytoﬂuorimetry proﬁles of Vero cells infected with
pseudoviruses produced with the different packaging constructs shown in Fig. 1. The proﬁles are representative of
several experiments. (B) Quantiﬁcation of cytoﬂuorimetry data shown in panel A (n 12, 9, 15, and 11 for the WNV,
DENV2, DENV2 T101Gmutant, and ZIKV packaging constructs, respectively). (C) A nonreducing Western blot (upper
panels) of cell extracts and pellets of ultracentrifuged supernatants of HEK293T cells cotransfected with the
WNV-rep and the indicated packaging constructs is shown. Protein E was detected with the ﬂavivirus-speciﬁc mAb
4G2. Actin was used as a loading control. The bottom panel shows the results of agarose gel analysis of RT-PCR
products of the same supernatants. DNA stained with ethidium bromide.
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We next investigated processing by the signal peptidase at the Ca-Pr peptide
junction of chimeric constructs and the performance of the different Ca as secretion
signals. For this purpose, Ca from DENV2, ZIKV, and WNV with wild-type or chimeric Pr
N-terminal amino acids were used as signal peptides on an irrelevant secretory soluble
reporter protein (a VHH-Fc fusion protein). We utilized, as a positive control, an
efﬁcient immunoglobulin-derived signal peptide (sec) frequently used for different
secretory proteins (29, 30) (Fig. 4D). Western blot analysis of intracellular and secreted
protein levels showed that all three Cas allowed secretion of the reporter protein with
an efﬁciency comparable to sec, irrespective of the 5 amino acids immediately down-
FIG 3 Generation and characterization of Zika pseudoviruses. (A) Scheme and sequence at the C-Pr junction of
different C-PrME ZIKV/WNV chimeras used as packaging constructs and numbered 1 to 6. WNV-derived sequences
are shown in red. The superscripts Z and W indicate sequences derived from ZIKV and WNV, respectively. (B)
Representative cytoﬂuorimetry proﬁles of Vero cells infected with the indicated ZIKV/WNV chimeric pseudoviruses.
(C) Quantiﬁcation of pseudovirus production determined by cytoﬂuorimetry and expressed as a percentage of
EGFP-expressing Vero cells at 24 hpi (n  11, 7, 5, 6, 7, and 7, for packaging constructs 1 through 6, respectively).
A multiple t test was used to analyze statistic differences between wild-type and chimeric pseudoviruses. (D)
Western blot analysis of intracellular protein levels and secreted virions in cell lysates and pellets of ultracentrifuged
supernatants of HEK293T cells transfected with the indicated packaging constructs. E protein was detected with the
ﬂavivirus-speciﬁc mAb 4G2. Actin was used as a loading control.
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stream of the cleavage site (Fig. 4E). Thus, the comparable signal peptide activity of
each Ca and their ability to be cleaved by the signal peptidase suggest that the
differences observed in pseudovirus production are not a consequence of impaired
translocation efﬁciency.
Effect of Ca on VLPs secretion. We then analyzed the role of Ca in the production
of virus-like particles (VLPs), which correspond to secretory vesicles harboring the PrME
viral proteins without the nucleocapsid core. Although VLPs are not identical to viral
particles, they represent structures that assemble into membranous vesicles, are se-
creted, and show antigenic properties similar to infectious viruses. For this purpose, we
used constructs encoding ZIKV PrME with Ca from ZIKV or WNV as signal peptides (Fig. 5A,
left panel). The nonviral sec signal peptide was used as a control. Western blot analysis of
cell extracts and ultracentrifuged supernatants (to concentrate secreted VLPs) were in line
with the production of pseudoviruses. VLPs were produced at higher levels and secreted
only in the presence of its homologous CaZ (Fig. 5A, right panel). The vesicular nature of the
secreted material was conﬁrmed by treating supernatants with a nonionic detergent
(NP-40, 0.5%) before ultracentrifugation. As expected, this treatment dissolved the mem-
brane of the vesicles present in the supernatant, which did not sediment by ultracentrif-
ugation. Further, we used DENV2 VLP constructs with different Cas to analyze whether
these replacements had the same impact on a different ﬂavivirus (Fig. 5B, left panel). The
FIG 4 Cleavage by NS2B/NS3 viral protease and signal peptidase. (A) Schematic representation of packaging construct carrying
the SV5 tag at the C N terminus. Ca sequence derived from WNV (CaW) is shown in red. (B) Western blot analysis of cellular
extracts of HEK293T cells transfected with the constructs shown in panel A in the absence () or presence () of the WNV-rep.
The migration of C, CPrM, and CPrME are indicated. (C) Representative cytoﬂuorimetry proﬁle of cells infected with
pseudoviruses produced with the packaging constructs shown in panel A. (D) Scheme of the Ca from ZIKV, WNV, and DENV2
(CaZ, blue; CaW, red; and CaD, black) used as signal peptides on an irrelevant secretory reporter protein. The nonviral signal
peptide sec (gray) is also shown. The vertical line indicates signal peptidase cleavage site. All constructs contain the ﬁrst 5
amino acids of viral Pr indicated as reported previously (5) using the same color code. (E) Western blot of cell extracts (E) and
culture supernatants (S) of cells transfected with constructs shown in panel D. Reporter protein was developed with
anti-mouse IgG. Actin was used as a loading control.
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results showed that, in contrast to ZIKV, DENV2 VLPs were produced even when the
homologous CaD was replaced with the ones from ZIKV and WNV but not with the
control sec (Fig. 5B, right panel). This indicates that, while ZIKV strictly requires its
homologous Ca, DENV is more permissive to other virus-derived sequences but remains
refractory to the nonviral one.
In contrast to what we observed with VLP constructs, secretion of a soluble version
of ZIKV dimeric E protein (sE-cvD, which lacks its own stem and C-terminal anchor
sequences and carries a A264C mutation to induce covalent dimerization) (31) was
efﬁcient with both Ca and the control sec, independently of the presence or absence
FIG 5 Secretion of VLPs and soluble E (sE). (A and B, left panels) Schemes of VLPs encoding constructs (PrME) of ZIKV (A) and DENV2 (B),
with CaZ (blue), CaW (red), CaD (black) or the nonviral sec (gray), as signal peptides. Right panels show nonreducing Western blots of
cellular extracts (E), culture supernatants (S), and ultracentrifuged pellet fraction (P; shown with [] or without [] 0.5% NP-40) of HEK293T
cells transfected with the ZIKV (A) or DENV2 (B) VLP constructs. Protein E was detected with mAb 4G2. (C and D, left panels) Schemes of
constructs encoding the covalent dimer (cvD) format of ZIKV PrMsE (C) or sE (D) with CaZ (blue), CaW (red), or the nonviral sec (gray), as
signal peptides. Right panels show nonreducing Western blots of cellular extracts (E) and culture supernatants (S) of transfected HEK293T
cells developed with anti-SV5. Arrows indicate the position of dimeric E.
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of PrM (Fig. 5C and D). We decided to use the cvD variant of ZIKV sE because, as we
have previously shown (31), the dimeric protein is properly folded and secreted from
mammalian cells and is closer to the settings in which vesicles are formed (dimerized
E). Taken together, these results strongly suggest that Ca is not just a signal for PrM
translocation but plays a crucial role in the assembly of VLP vesicles.
Ca determines E protein stability. The largely reduced intracellular levels of the E
protein expressed from the chimeric packaging and VLP constructs (Fig. 3B and 5A)
suggested activation of a degradation pathway. This was conﬁrmed in cells transfected
with CaW-PrMEZ or CaZ-PrMEZ after cycloheximide (CHX) treatment (Fig. 6A). While E
expressed from the chimeric construct with the heterologous CaW was actively degraded,
the one produced from the construct with the homologous CaZ was not (Fig. 6B). To
analyze the degradation pathway, transfected cells were treated with a lysosomal
inhibitor (chloroquine [CQ]) or a proteasome inhibitor (MG132) along with CHX. CQ
treatment completely rescued expression, while treatment with MG132 did it only
partially (Fig. 6C). Further, Western blot analysis of cells extracts from VLP-transfected
cells after CQ treatment showed accumulation of protein E and LC3-II (microtubule-
associated protein 1 light chain 3), a marker of autophagy (32) (Fig. 6D), indicating that
degradation occurs mainly through the autophagy-lysosomal pathway. LC3-II is known
to be partially degraded with the target protein (33). Subsequently, activation of
autophagy was studied by confocal microscopy with an anti-LC3 antibody recognizing
both nonlipidated (LC3-I) and lipidated (LC3-II) forms, and an anti-E serum speciﬁc for
ZIKV domain III (DIII) produced by immunizing BALB/c mice. As shown in Fig. 6E robust
expression of E and a low number of LC3 puncta was observed in cells transfected with
the CaZ-PrMEZ construct. In contrast, but in agreement with the activation of au-
tophagy, in cells transfected with the chimeric CaW-PrMEZ, E was undetectable but a
large increase in LC3 puncta was observed. Further evidence was obtained by small
interfering RNA (siRNA) silencing of Atg7. LC3 is produced as a precursor protein, which
is ﬁrst cleaved by Atg4 to generate LC3-I and then by Atg3 and Atg7 to generate the
lipidated form LC3-II that is associated with autophagic vesicles. Confocal microscopy
showed that, whereas Atg7 silencing had no effect on E expressed from the wild-type
construct, it did induce E accumulation when expressed from the chimeric CaW-PrMEZ
compared to cells treated with an irrelevant siRNA (Fig. 6F). These results were conﬁrmed
by Western blot analysis of E and endogenous LC3 protein levels as well (Fig. 6G).
Furthermore, electron microscopy studies have shown that the cytoplasm of cells
expressing CaW-PrMEZ was enriched in late endosome/multivesicular bodies and or-
ganelles of the degradative compartment/autolysosomes (Fig. 6H). Overall, these re-
sults indicate that the single replacement of the homologous Ca with a closely related
one was sufﬁcient to induce activation of the autophagy pathway resulting in degra-
dation of protein E and therefore impaired pseudovirus assembly.
Effect of Ca on the assembly of infective particles.We then investigated whether,
in addition to the Ca role in determining stability of the packaging structural proteins,
Ca-mediated anchoring of C to the ER membrane is also required for virus morpho-
genesis. To achieve this, we analyzed the production of pseudoviruses using a tripartite
system: C and PrME were expressed in trans from two different constructs instead of the
classical cis C-PrME and cotransfected with the WNV replicon (Fig. 7A). We used ZIKV C
in two different versions: one with its own CaZ and one without any anchor. The ZIKV
PrME constructs instead had different Cas or a sec (as a nonviral control sequence) as
a secretion signal (Fig. 7B). Pseudoviruses were produced with PrME constructs con-
taining CaZ, but not with CaW or sec, regardless of whether C was anchored to the ER
membrane (C-CaZ) or not (C) (Fig. 7C and D). Secretion of ZIKV pseudoviral particles was
conﬁrmed by Western blotting and RT-PCR (Fig. 7E). The higher efﬁciency of pseudo-
virus production when C was expressed without any anchor at its carboxy terminus was
most likely due to the lower levels of soluble C produced from the C-CaZ construct in
the presence of the nonstructural viral proteins (WNV-rep) because of incomplete
processing (Fig. 7F, left panel). Interestingly, we observed that cleavage efﬁciency by
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the viral protease was largely improved (almost complete) in the presence of PrM (Fig.
7F, right panel).
Taken together, our results demonstrate that (i) the viral Ca is strictly required at the
N-terminal side of PrM for proper assembly of infective particles, since PrM constructs
FIG 6 Degradation of ZIKV E protein. (A) Schematic representation of ZIKV VLP encoding constructs. (B) Western blot analysis
at different time points of cellular extracts after CHX (, 100 g/ml) treatment at 16 h posttransfection. (C) CHX treatment of
CaW-PrMEZ-transfected cells in the presence of chloroquine (CQ; 100 M) or MG132 (20 M). (D) Western blots of CaZ-PrMEZ-
and CaW-PrMEZ-transfected cells treated () or not treated () with CQ (50 M). An arrowhead indicates LC3-II. (E and F)
Confocal immunoﬂuorescence of HeLa cells transfected with ZIKV VLP (wt and chimeric) using anti-ZIKV DIII sera and anti-LC3.
In panel F, HeLa cells were transfected with the indicated siRNAs 48 h before transfection with ZIKV VLP constructs. siNT is a
control nontargeting siRNA. Scale bar, 20 m. (G) Western blot analysis of proteins E and LC3 in HEK293T cellular extracts
treated with the indicated siRNAs and transfected with the wt and chimeric ZIKV VLP constructs. (H) Representative electron
microscopy image of a cell cotransfected with WNV-rep and the CZ-CaW-PrMEZ packaging construct. Arrowheads indicate
autolysosomes/degradative compartments. PM, plasma membrane; N, nucleus; mv, multivesicular bodies. Scale bar, 500 nm.
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with other signal peptides that allow efﬁcient translocation into the lumen were unable
to assemble even when coexpressed with C-Ca, and (ii) C anchorage to the ER
membrane is not essential for the formation of nucleocapsid and virus assembly, which
is consistent with the requirement of sequential cleavage on the cytosolic side before
cleavage by the signal peptidase.
DISCUSSION
The topological distribution of structural and nonstructural proteins is a conserved
characteristic feature of ﬂaviviruses, which have a replication and assembly strategy
centered on attachment to the ER membranes. With the exception of NS1, most of the
nonstructural proteins are mainly facing the cytosolic side and remain attached to the
ER membrane either by their own TMDs or through interactions with other NS proteins.
FIG 7 Tripartite production of pseudoviruses. (A) Schematic representation of the tripartite system of transfection for the
production of pseudoviruses. (B) Packaging constructs used. ZIKV C was expressed alone (C) or fused to its own anchor CaZ
(blue, C-CaZ), while ZIKV PrME was expressed with the indicated Ca (or sec), as signal peptides. (C) Representative cytoﬂuo-
rimetry proﬁles of Vero cells infected with ZIKV pseudoviruses produced with the indicated set of trans packaging constructs.
(D) Quantiﬁcation of ZIKV pseudoviruses production determined by cytoﬂuorimetry of infected Vero cells at 24 hpi (n  6 in
all cases). (E) Nonreducing Western blot (upper panels) of cell extracts and pellets of ultracentrifuged supernatants of HEK293T
cells, transfected with the indicated packaging constructs and developed with mAb 4G2. The bottom panel shows an agarose
gel of RT-PCR products of the same supernatants stained with ethidium bromide. (F) Western blot analysis of cellular extracts
of HEK293T cells cotransfected with ZIKV SV5-tagged constructs C and C-Ca (left panel) or C-Ca and C-PrME (right panel) and
without () or with () WNV-rep. Cleaved and uncleaved C are indicated by red and black arrows, respectively.
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The two structural proteins M and E associated with the virus envelope have both
double-spanning transmembrane domains that serve as anchors to expose the proteins
to the lumen of the ER. The role of their TMDs in the assembly and release of infective
particles has been extensively studied in the context of other ﬂaviviruses like tick borne
encephalitic virus and Yellow fever virus (16, 20). Conversely, little is known of the Ca
transmembrane domain, which has long been considered as a signal peptide to allow
translocation of PrM into the ER lumen. Here, we show that Ca plays a signiﬁcant role
in ZIKV morphogenesis by controlling E protein stability, thus making it an essential
determinant for assembly of infective particles.
In other viruses signal sequences have also been shown to play additional roles. In
hepatitis C virus (HCV), a member of the Flaviviridae family (Hepacivirus genus), the
signal peptide at the C terminus of the core protein (equivalent to Ca in ZIKV) allows
secretion of nonenveloped nucleocapsids a phenomenon that contributes to persistent
infection and escape from immune surveillance (34, 35). It has also been shown that this
transmembrane signal peptide is responsible for lipid accumulation in infected cells
causing steatosis (36). In alphaviruses, such as Semliki Forest virus and Sindbis virus, the
signal peptide of p62 is found in mature viral particles associated with the complex
formed by E1-E2 glycoproteins (37), whereas in the lymphocytic choriomeningitis virus
the long extended N-terminal sequence (58 amino acids) of glycoprotein C remains
anchored to the viral membrane after cleavage by the signal peptidase and plays a role
in glycoprotein maturation and virus infectivity (38).
In this study, we used a pseudovirus-based system that allows production of
infective particles. Infectivity was determined as a function of the expression of the
EGFP reporter encoded in the WNV replicon. This approach has been previously used
to study different aspects of ﬂavivirus life cycle (39–44).
To understand the role of Ca in viral life cycle, different chimeras were generated by
replacements of C and/or Ca on the ZIKV packaging constructs. We took advantage of
the strict requirement shown by ZIKV, which only permits its own Ca to produce
pseudoviruses and VLPs. This was surprising since the Cas of other viruses, like that of
WNV, have a closely related sequence. Previous studies in other ﬂaviviruses have shown
that replacement of TBEV Ca with that of JEV, a distantly related ﬂavivirus, did not
impair virion formation or infectivity of viral particles (20), highlighting a permissiveness
not present in ZIKV. In contrast, replacement of PrME from DENV2 with that of ZIKV
without the exchange of Ca failed to produce infectious chimeric viruses (45). This was
also true when pseudoviruses were produced in other cell lines such as HeLa and Vero
cells (data not shown). In addition, a study on a ZIKV VLP-based vaccine showed that
replacement of the signal sequence of PrM (i.e., Ca) and the TMDs of E with those of JEV
improved the secretion of VLPs (46). These contrasting data indicate that different
ﬂaviviruses show markedly different permissiveness following the replacement of
structural components.
To understand how the replacement of Ca in ZIKV structural polyprotein affected
production of viral and subviral particles, we ﬁrst ruled out impairment of the cytosolic
and luminal cleavages of Ca using different packaging constructs. The signal peptide
activity was tested on both viral sE and an irrelevant secretory protein, and the results
showed that this function was not dependent on the downstream-encoded protein.
However, different Cas clearly showed distinct activities when we assessed their ability
to produce VLPs, which are the result of coexpression of PrME and require incorpora-
tion of the two membrane proteins into a lipid vesicle. In this context, only the
homologous Ca was permissive for assembly of VLPs. Interestingly, the nonviral leader
peptide (sec) was completely incompetent in allowing production of pseudoviruses or
VLPs, even with the DENV2 construct, which is highly permissive to heterologous Ca
sequences. This suggests that the virus-derived Ca sequences have been selected for a
function that goes beyond their capacity to allow PrM translocation to the ER lumen.
It was clear that the replacement of Ca abolished the production of pseudoviral
particles by strongly reducing the intracellular levels of protein E. The experiments
performed in the presence of inhibitors indicated that enhanced E degradation took
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place preferentially through activation of the autophagy/lysosomal pathway. These
results were further conﬁrmed by electron microscopy and immunoﬂuorescence anal-
ysis using anti-E and anti-LC3 antibodies and Atg7 silencing. Other studies have shown
that the accumulation of large protein aggregates in the ER triggers the autophagy-
dependent degradation pathway (47). One possibility is that Ca actively participates in
the folding of PrM and/or E. However, since proper folding of the extracellular domains
of E (sE) can be efﬁciently achieved even in the absence of Ca and PrM (31), this putative
role for Ca might be dependent on anchorage of the proteins to the ER membrane
through their TM domains. In this scenario, Ca might be required to allow proper
interactions and assembly of PrME complexes, which are otherwise actively targeted to
degradation. Since Ca is a short hydrophobic sequence embedded in the ER mem-
brane, the different tolerances of exogenous Ca sequences by different ﬂaviviruses
suggest complex interactions taking place between Ca and the TM domains of M
and/or E. Surprisingly, the lack of permissive interactions leads to activation of a
degradation pathway. In agreement with the existence of these interactions, the
secretion of E with exogenous Ca in the absence of PrM and of its own TMs was also
well tolerated by ZIKV.
Interestingly, the experiments with the tripartite system for the production of
pseudoviruses showed a strict requirement for CaZ to be expressed in cis with respect
to PrME. In fact, providing CaZ in trans (as when expressed fused to C in C-CaZ
construct) was not sufﬁcient to allow assembly into vesicles. In agreement with our
results, transcomplementation studies on MVEV, YFV, and Kunjin viruses have also
shown reduced pseudovirus assembly when C-Ca and PrME proteins were translated
from separate coding units (23, 41, 48, 49).
It was not surprising to ﬁnd that protein C does not require anchorage to the ER
membrane for the formation of the nucleocapsid and assembly into infectious particles,
since this is consistent with the sequential cleavage requirement on the cytosolic side
before processing by the signal peptidase. Moreover, soluble C was more efﬁcient in
packaging WNV-rep than the membrane-anchored C, most likely because in the
absence of the downstream Pr peptide, Ca processing efﬁciency on the cytosolic side
was affected. These results are consistent with a previous report showing that in YFV
efﬁcient cleavage was dependent on the Pr peptide sequence downstream (49).
In conclusion, our study shows that ZIKV assembly and maturation rearrangements
involve not only the transmembrane domains of the lipid-embedded M and E proteins,
but also Ca, which determines E stability controlling activation of the autophagy/
lysosomal pathway.
MATERIALS AND METHODS
Cell lines, monoclonal antibodies, and chemicals. HEK293T (CRL-11268; ATCC, Rockville, MD) and
Vero (ATCC CCL-81) cells were cultured in Dulbecco modiﬁed Eagle medium (DMEM; Life Technologies,
Paisley, UK) supplemented with 10% heat-inactivated fetal calf serum (FCS; Life Technologies), 50 g/ml
gentamicin, and 2 mM L-glutamine. Unless indicated otherwise, all cells were incubated at 37°C in the
presence of 5% CO2. For the expression of covalent E dimers, transfected cells were incubated at 28°C
instead of 37°C. Flavivirus E protein-speciﬁc mAb 4G2 was expressed as a scFv (50; NCBI accession codes
KJ438784 and KJ438785) fused to avidin in a format called avibody (A. Predonzani and O. R. Burrone,
unpublished data) and used as cultured supernatant from HEK293T-transfected cells. mAb SV5 was
obtained as previously described (30). The ZIKV-speciﬁc anti-DIII serum was produced by immunizing
BALB/c mice with a DNA construct encoding the DIII-CH3 as reported previously (30).
For protein degradation analysis, HEK293T cells were treated with the translation inhibitor cyclohex-
imide (100 g/ml; Sigma), the proteasomal inhibitor MG132 (20 M; Calbiochem), or the autophagy
inhibitor chloroquine (50 M; Sigma) at 16 h posttransfection, and the cells were collected at different
time intervals after treatment to analyze the protein levels.
Plasmid DNA constructs. The gene fragments encoding the structural proteins (CPrME) from ZIKV
MR766 strain (GenBank accession number AEN75266.1) and DENV2 NGC strain (GenBank accession
number AAA42941) were obtained as a synthetic, mammalian-codon optimized genes (GenScript,
Piscataway, NJ) and cloned into pVAX1 expression vectors (Life Technologies). The WNV packaging
construct and the DNA-launched WNV subgenomic replicon expressing EGFP (here named WNV-rep)
were kindly provided by Theodore Pierson (National Institute of Allergies and Infectious Diseases,
Bethesda, MD) (27). The chimeric packaging constructs were obtained either by cloning or site-directed
mutagenesis (QuikChange XL site-directed mutagenesis kit; Agilent Technologies, La Jolla, CA) according
to the manufacturer’s instructions.
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Capsid, PrME, and PrMsE encoding constructs were obtained by cloning the sequence of interest into
pVAX1 expression vector after a PCR ampliﬁcation of the fragment from the packaging constructs. PrMsE
constructs were fused to a carboxy-terminal SV5 tag (GKPIPNPLLGLD) for the detection of the soluble
protein (PrMsE-SV5) (51). sE-SV5 constructs were obtained after directed deletion of PrM from PrMsE-SV5
plasmids.
Production of pseudoviral particles and VLPs. Pseudoviral particles were produced as previously
described (52). Brieﬂy, the WNV-rep and plasmids expressing the wild-type (WT) or chimeric packaging
constructs of WNV, ZIKV, and DENV2 (1:3 WNV-rep/packaging construct ratio) were cotransfected into
HEK293T cells using linear polyethylenimine (molecular weight, 25,000; Polysciences, Warrington, PA) in
a 1:3 DNA/polymer ratio. When the structural genes were provided in trans, the WNV-rep, PrME, and C
gene constructs were used at a 1:1:4 ratio, respectively. At 16 h posttransfection, the culture medium was
replaced by DMEM with 7% FCS, and pseudoviruses were harvested after 24 h of incubation at 37°C.
Supernatants were clariﬁed by centrifugation and stored at 20°C until use. Using the same protocol,
VLPs were obtained by transfecting the PrME constructs into HEK293T cells. When needed, the culture
supernatant was ultracentrifuged with a Beckman Coulter Airfuge centrifuge using a A100/18 rotor at
149,000  g for 2 h at 4°C, and the pellet containing either pseudoviruses or VLPs was resuspended in
nonreducing sample buffer for Western blot analysis.
Infection of Vero cells. A total of 4  104 Vero cells were seeded in 24-multiwell plates 24 h before
infection. The culture medium was removed, and the cells were infected with 200 l of pseudoviral
preparations for 3 h at 37°C. Then, 0.5 ml of DMEM with 2% FBS was added, and the cells were cultured
for 24 h. Cell infection was determined by measuring the percentage of EGFP-positive cells in cytoﬂuo-
rimetric analysis in a FACSCalibur (BD Biosciences, San Jose, CA).
Expression of secretory proteins. Standard calcium phosphate transfections were performed on
HEK293T cells in 6-multiwell plates as previously described (53). After overnight incubation at 37°C, the
culture medium was replaced with serum-free DMEM, and the cells were incubated for another 24 h at
37 or 28°C, depending on the construct. The culture supernatants were then cleared by centrifugation,
and cellular extracts were prepared in 100 l of TNN lysis buffer (100 mM Tris-HCl [pH 8], 250 mM NaCl,
0.5% NP-40) supplemented with protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Samples were
stored at 20°C until use.
siRNA transfection. For siRNA experiments, 5  104 HeLa cells/well and 1  105 HEK293T cells were
seeded in 12-multiwell plates and transfected with 0.1 nmol of annealed duplex siRNA (Sigma) using 5
l of RNAiMAX Lipofectamine 2000 (Life Technologies) according to the manufacturer’s protocol. The
following siRNAs were transfected: siAtg7 (5=-GGUCAAAGGAUGAAGAUAA-3=) and a control nontargeted
siRNA, siNT (5=-UCGUCUUCUACAACGUCAATT-3=). At 48 h posttransfection, the medium was changed,
and the cells were allowed to grow for 24 h, followed by transfection with VLP constructs. The next day,
HeLa cells were used for immunoﬂuorescence, and HEK293T cells were used for Western analysis.
Western blotting. Western blot analyses of untagged and SV5-tagged proteins were done as
previously reported (30). Brieﬂy, samples were separated by nonreducing SDS-PAGE, transferred to
polyvinylidene diﬂuoride membranes (Millipore, Temecula, CA) and blocked with 5% milk solution in
phosphate-buffered saline (PBS-milk). Afterward, the membranes were incubated for 1 h with the 4G2
avibody or anti-SV5 mAb and washed. For SV5-tagged proteins, membranes were incubated for 1 h with
anti-SV5 mAb (1 g/ml), washed, and further probed with HRP-linked anti-mouse IgG goat antibodies
(catalog no. 074-1809, 1:10,000; KPL, Gaithersburg, MA) for 1 h. 4G2 avibody was previously treated with
biotinylated-HRP (ThermoFisher-Pierce, Rockford, IL, USA), incubated for 1 h, and washed. Mouse
HRP-conjugated anti-actin (clone AC-15, 1:30,000; Sigma-Aldrich) was used as loading control. Signals
were developed by ECL (Thermo Fisher-Pierce, Rockford, IL).
RT-PCR. WNV replicon-derived RNA was isolated from 100 l of pseudoviral preparations using the
RNAzol-BEE solution (Tel-Test, Friendswood, TX) and then treated with DNase I (Promega, Madison, WI)
according to the manufacturer’s instructions. Reverse transcription was performed using random hex-
amers (Sigma) and Moloney murine leukemia virus reverse transcriptase (Life Technologies) according to
the manufacturer’s protocol. cDNAs were then ampliﬁed by PCR using WNV-3= untranslated region-
speciﬁc primers (forward, 5=-CAGTGTCAGACCACACTTTAATGT-3=; reverse, 5=-GCTTACAGCTTCAGCCA
AG-3=).
Immunoﬂuorescence microscopy. For immunoﬂuorescence, 5  104 HeLa cells/well were seeded
in 12-multiwell plate and transfected with VLP constructs using calcium phosphate. The cells were ﬁxed
with 4% paraformaldehyde (PFA) at 24 h posttransfection, and immunoﬂuorescence experiments were
performed as described previously (54) using the following antibody dilutions: mouse ZIKV anti-DIII sera
(1:100), anti-LC3B rabbit antibody (1:200; Sigma), Alexa Fluor 647 conjugated anti-mouse (1:500; Life
Technologies), Alexa Fluor 488-conjugated anti-rabbit (1:500; Life Technologies). Samples were analyzed
by an LSM510 confocal microscope (Zeiss, Gottingen, Germany) equipped with a 100 NA 1.3 objective.
Electron microscopy. HEK293T cells were ﬁxed at 20 h posttransfection as a monolayer in 2%
glutaraldehyde–0.1 M cacodylate buffer for 30 min at room temperature, scraped, collected as a pellet,
and supplemented with fresh ﬁxative for 24 h at room temperature. Cell pellets were further processed
and embedded in epoxy resin. Thin sections were observed with a Philips CM10 transmission electron
microscope, and images were acquired at a ﬁnal magniﬁcation of 25,000 to 34,000 using a Morada
CDD camera (Olympus, Munster, Germany).
Statistical analysis. Data were obtained from at least six independent experiments performed in
duplicate or triplicate. Unless indicated otherwise, arithmetic means  standard deviations were calcu-
lated. A nonparametric Mann-Whitney test for median comparison was used when required (Prism 6.0;
GraphPad Software, Inc., La Jolla, CA); in all cases P values of 0.005 were considered signiﬁcant. The
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sample size was not statistically assessed, and no randomization was done. The researchers involved
were not blind for data collection or analysis.
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